Promises and forecasts attributed to SK Bioscience in news reports, sealed when reported. A record shows what was reported as said, with the original link; it is not a judgement of the person.
SK Bioscience said Thursday it will join a Bundibugyo virus vaccine development project backed by up to $99 million from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority.
OPEN · DUE 27 APR 2027said 29 Oct 2026Promiserecord →